InnoCare Pharma Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 46.34% vs 125.94% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 645.81% vs 109.78% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "596.50",
          "val2": "407.60",
          "chgp": "46.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "76.40",
          "val2": "3.60",
          "chgp": "2,022.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.20",
          "val2": "14.50",
          "chgp": "11.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.80",
          "val2": "2.70",
          "chgp": "40.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "115.60",
          "val2": "15.50",
          "chgp": "645.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "128.10%",
          "val2": "-68.50%",
          "chgp": "19.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 136.12% vs 33.79% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 242.28% vs 31.17% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,557.90",
          "val2": "1,083.30",
          "chgp": "136.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "618.90",
          "val2": "-474.60",
          "chgp": "230.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "59.70",
          "val2": "37.10",
          "chgp": "60.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.40",
          "val2": "-33.00",
          "chgp": "110.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "698.60",
          "val2": "-491.00",
          "chgp": "242.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "191.80%",
          "val2": "-545.30%",
          "chgp": "73.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

596.50

407.60

46.34%

Operating Profit (PBDIT) excl Other Income

76.40

3.60

2,022.22%

Interest

16.20

14.50

11.72%

Exceptional Items

3.80

2.70

40.74%

Consolidate Net Profit

115.60

15.50

645.81%

Operating Profit Margin (Excl OI)

128.10%

-68.50%

19.66%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 46.34% vs 125.94% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 645.81% vs 109.78% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,557.90

1,083.30

136.12%

Operating Profit (PBDIT) excl Other Income

618.90

-474.60

230.40%

Interest

59.70

37.10

60.92%

Exceptional Items

3.40

-33.00

110.30%

Consolidate Net Profit

698.60

-491.00

242.28%

Operating Profit Margin (Excl OI)

191.80%

-545.30%

73.71%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 136.12% vs 33.79% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 242.28% vs 31.17% in Dec 2024

All Annual Results